Home
|
News
|
Events
|
Contact Us
|
English
|
繁體中文
|
日本語
About Us
Product & Service
Facilities
Quality & Compliance
For Investors
Career
|
Company
|
Milestone
|
People
|
Mission Statement
|
Organization
|
Contact Us
|
|
Active Pharmaceutical Ingredients
|
Contract Development and Manufacturing Organization (CDMO)
|
Antibody Drug Conjugates (ADCs)
|
Injectable Manufacturing Services
|
|
Kilo Lab
|
Commercial Production
|
High Potency API (HPAPI)
|
Analytical instrument
|
|
DMFs & CEPs
|
Inspection
|
Certificates
|
SHE Policy
|
Intellectual Property
|
Award
|
|
Financials
|
Corporate Governance
|
Shareholder Services
|
Sustainable Development
|
FAQ
For Investors
Home
/
For Investors
/
Corporate Governance
/
Major Resolutions
Major Resolutions
111年度董事會決議事項
110年度董事會決議事項
109年度董事會決議事項
108年度董事會決議事項
107年度董事會決議事項
106年度董事會決議事項
105年度董事會決議事項
104年度董事會決議事項
103年度董事會決議事項
102年度 董事會決議事項
101年度 董事會決議事項
100年度 董事會決議事項
Financials
Annual Reports
Monthly Revenue
Finacial Reports
Corporate Governance
Board of Directors
Major Policies
Internal Audit
Major Resolutions
Shareholder Services
Stock Quotes & Dividend Data
Material Announcement
Shareholders' Meeting
Activities
Sustainable Development
Sustainable Development
Stakeholder Engagement
Public Welfare
FAQ
Common Share Transfer
Contacts
FAQ
Copyright ©2014 Formosa Laboratories, Inc. All Rights Reserved.
丙肝
